← Eichor
Study identifier: NCT06885671 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy

Condition: Breast Cancer Early Stage Breast Cancer (Stage 1-3)  ·  Sponsor: British Columbia Cancer Agency

PhaseNA
Planned participants60
Who can joinFemale, 40 Years to no upper limit
Healthy volunteersNo

About this study

Partial Breast Irradiation (PBI) is a targeted radiation approach commonly administered post-lumpectomy, specifically targeting the tumour bed. This targeted therapy reduces the exposure to other nearby tissues such as lungs, heart, and chest wall. However, traditional PBI treatment involves lengthy multiple fraction courses which presents a burden to patients from rural and remote communities, who must travel long distances to receive high quality cancer care. The purpose of this study is to compare single fraction (SF) PBI vs. multiple fraction (MF) PBI.

This description comes directly from the study's public registry record.

Talk to the study team

Robert Olson, MD, MSC, FRCPC  ·  250-645-7300  ·  rolson2@bccancer.bc.ca

Lindsay Mathews  ·  250-645-7300  ·  lindsay.mathews@bccancer.bc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

BC Cancer - Prince GeorgePrince George, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06885671